After the surge, the settling
Telehealth's story has been told in two acts so far. Act one was the pandemic surge, when video visits went from rounding error to lifeline in a matter of weeks. Act two was the correction: utilization fell back, a wave of undifferentiated telehealth startups folded or merged, and skeptics declared the experiment over.
They were wrong, but in an interesting way. Telehealth did not return to its pre-2020 baseline — it settled at a level several times higher, concentrated in the specialties where it genuinely works. Behavioral health leads by a wide margin, where remote care remains a substantial access channel in many systems. What we are watching in 2026 is act three: the unglamorous, consequential work of making virtual care a permanent, well-governed layer of the health system rather than a novelty bolted onto it.
Seven trends define this phase. Together they sketch a picture of virtual care that is more integrated, more accountable and considerably more interesting than the hype cycle that preceded it.
Hybrid care becomes the default
The most important shift is conceptual: leading health systems have stopped treating telehealth as a separate service line. Instead, virtual and in-person touchpoints are being woven into single care journeys — an in-person diagnosis followed by virtual titration visits, remote monitoring between appointments, and asynchronous check-ins that decide whether the next visit needs to happen at all.
This sounds obvious, but operationally it is hard. Scheduling systems, clinician workflows and reimbursement structures were all built around discrete, billable encounters. The systems getting hybrid care right invest in explicit triage rules: which needs require an exam room, which can be handled by video, which can move to secure messaging, and when a clinician must escalate. The payoff shows up in access metrics: shorter waits for new-patient appointments, because low-acuity follow-ups no longer occupy exam rooms.
The rise of asynchronous medicine
The fastest-growing slice of virtual care is not video at all. Asynchronous visits — structured questionnaires, store-and-forward images, secure messaging exchanges reviewed by a clinician on their own schedule — are expanding quickly in dermatology, urgent care and medication management for stable chronic conditions.
The economics explain the momentum. An asynchronous encounter takes a clinician a fraction of the time a video visit requires, which matters enormously in a workforce shortage. Patients, meanwhile, increasingly prefer it for simple needs: no appointment, no waiting room, virtual or otherwise. The open questions are clinical governance ones — which presentations are safe to handle without a live conversation, and how to ensure escalation pathways actually get used. Expect specialty societies to publish much firmer guidance this year.
Payment parity gets settled, unevenly
The regulatory fog that hung over telehealth economics for years is finally lifting, though the resulting map is patchwork. Most states now have some form of payment parity law for commercial insurance, and federal policy has made permanent many of the pandemic-era flexibilities for behavioral health. Coverage for other specialties still varies by state, payer and modality — asynchronous care in particular remains inconsistently reimbursed.
The strategic consequence: telehealth business models built on regulatory arbitrage are dying, and models built on genuine cost advantage are compounding.
For providers, the practical advice has not changed: build your virtual care economics assuming parity where it exists and documented efficiency gains where it does not. The programs that survive audits and contract negotiations are the ones that can show total-cost-of-care impact, not just visit substitution.
Virtual-first primary care matures
Virtual-first primary care — plans and providers where the digital front door is the default and physical care is the escalation path — has moved past its awkward adolescence. The surviving players learned two hard lessons. First, "virtual-first" cannot mean "virtual-only"; members need credible, well-orchestrated pathways into labs, imaging and specialty care. Second, continuity beats convenience: members who see the same clinician repeatedly show meaningfully better outcomes and retention than those routed to whoever is available.
Employers remain the main buyers, drawn by the promise of lower total spend and better access for distributed workforces. The differentiator in 2026 is integration depth — the virtual-first providers winning contracts are those that can exchange records bidirectionally with local health systems rather than operating as data islands.
Specialty care goes virtual
Beyond primary and behavioral health, a second wave of specialty telehealth is gathering. Tele-oncology programs now handle survivorship visits and symptom management remotely. Virtual cardiology follow-up, paired with home blood pressure cuffs and wearable ECGs, is becoming standard for stable patients. Maternal-fetal medicine, endocrinology and post-surgical follow-up are all seeing serious virtual programs backed by outcome data rather than enthusiasm.
The pattern across specialties is consistent: virtual care works best for the longitudinal middle of the care journey — monitoring, adjustment, education, reassurance — while diagnosis and procedures stay physical. Programs designed around that division of labor are producing the strongest results.
Quality measurement grows teeth
For years, telehealth quality was measured by patient satisfaction scores, which measure friendliness more than medicine. That era is ending. Accreditation bodies and payers are rolling out virtual-care-specific quality measures: diagnostic concordance with in-person evaluation, appropriate antibiotic prescribing rates, escalation timeliness and equity of access across broadband and language barriers.
This is unambiguously good news for serious operators. Quality measurement raises the floor, exposes the corner-cutters and gives well-run programs a way to prove their value in contract negotiations. It also surfaces telehealth's genuine weak spots — most notably the risk of overprescribing in high-volume, low-continuity urgent care models — while giving the industry a framework for fixing them.
What to watch next
Three signals will tell you where act three ends. Watch whether asynchronous reimbursement stabilizes, because that determines how much of routine medicine moves off the calendar entirely. Watch the integration deals between virtual-first providers and regional health systems, because they will define whether virtual care becomes a partner or a competitor to bricks and mortar. And watch the first generation of AI-assisted triage tools entering virtual front doors — the subject of our companion analysis on AI diagnostics — because they will decide how far the digital front door can scale.
Telehealth's noisy years are over. Its important years are just beginning.
The policy reality behind the trends
Direct answer: telehealth in 2026 is not a single market trend; it is a regulated care modality whose usefulness depends on specialty, state rules, payer coverage, clinical risk and patient access. The current federal picture is clearer than it was during the pandemic unwind. Telehealth.HHS.gov says many Medicare telehealth flexibilities for non-behavioral and mental health care continue through December 31, 2027, including home-originating-site flexibility and audio-only use in some circumstances. HHS and DEA also extended controlled-medication telemedicine flexibilities through December 31, 2026 while permanent rules are finalized.
That means product teams should stop treating "video visit" as the trend. The durable work is routing, documentation, escalation, equity and prescribing governance. CMS still updates Medicare telehealth services through the physician fee schedule process, so any product tied to reimbursement needs an annual policy check rather than a one-time launch assumption.
For clinical leaders, the gap to close is measurement. Track which visits are resolved virtually, which are escalated, how quickly escalation happens, whether prescriptions follow the same guardrails as in-person care, and whether lower-bandwidth patients can still use the service. A virtual programme that improves access for commercially insured video users while excluding rural, older or audio-only patients is not mature; it is merely convenient for a narrow slice of demand.
For product teams, the practical backlog is equally concrete: show the patient's location and consent state, preserve documentation for payer audit, route emergencies out of chat immediately, capture interpreter needs, and make it easy for clinicians to choose in-person follow-up without fighting the interface. These are not glamorous features, but they are the difference between a telehealth product and a compliant care workflow.
Telehealth FAQ
- Is telehealth permanently covered everywhere?
- No. Some Medicare flexibilities are extended through 2027, but coverage still varies by service, payer, state and modality.
- Can controlled substances be prescribed by telehealth in 2026?
- Federal DEA/HHS flexibilities are extended through December 31, 2026, subject to legitimate medical purpose and state law.
- What should digital-health teams audit first?
- Triage criteria, escalation workflows, state licensure, documentation, prescribing controls and accessibility for audio-only or low-bandwidth users.